Baker McKenzie

Baker McKenzie’s Stockholm office sits at the forefront of the equity capital markets space in Sweden, with the team regularly handling IPOs, including on Nasdaq Stockholm and Nasdaq First North Growth Market, as well as rights issuances, ABBs, and public takeovers. The group is regularly instructed by domestic and international investment banks as underwriters’ counsel and is also noted for its life sciences expertise; acting for several banks in relation to Cinclus Pharma’s main market mid-segment IPO is a recent highlight for the team. Practice head Joakim Falkner has considerable experience representing late-stage private and publicly traded companies, investment banks, investors, shareholders, and sponsors on pre-IPO transactions, IPOs, primary share issuances, and preferential rights offerings. Henric Roth is active in the tech and life sciences spaces. Stefan Balazs and senior associate Johanna Flink are also key contacts.